Shuttle Pharmaceuticals Holdings (SHPH) Interest Coverage Ratio (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Interest Coverage Ratio came in at 7.39 in Q1 2026, up 49.92% year-on-year from 4.93 in Q1 2025, and up 67.4% quarter-over-quarter from 22.67 in Q3 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 7.39 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 49.92% year-over-year to 7.39 in Q1 2026; TTM through Mar 2026 was 18.64, a 52.86% decrease from a year earlier, with the FY2025 full-year figure at 1.53, down 0.54% from the prior year.
- Interest Coverage Ratio advanced to 7.39 in Q1 2026 per SHPH's latest filing, from 22.67 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 25.03 in Q4 2024 and bottomed at 49.29 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 9.94 (2026), against an average of 12.18.
- Biggest YoY gain for Interest Coverage Ratio was 3696.17% in 2024; the steepest drop was 494.86% in 2024.
- Year by year, Interest Coverage Ratio stood at 27.02 in 2022, then soared by 102.44% to 0.66 in 2023, then surged by 3696.17% to 25.03 in 2024, then tumbled by 190.56% to 22.67 in 2025, then surged by 67.4% to 7.39 in 2026.
- Per Business Quant, the three latest SHPH Interest Coverage Ratio figures stand at 7.39 (Q1 2026), 22.67 (Q3 2025), and 12.49 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | -7.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.39 |
| Sep 30, 2025 | -22.67 |
| Jun 30, 2025 | -12.49 |
| Mar 31, 2025 | -14.76 |
| Dec 31, 2024 | 25.03 |
| Sep 30, 2024 | -15.26 |
| Jun 30, 2024 | -3.44 |
| Mar 31, 2024 | -2.78 |
| Dec 31, 2023 | 0.66 |
| Sep 30, 2023 | -2.56 |
| Jun 30, 2023 | -2.67 |
| Mar 31, 2023 | -2.58 |
| Dec 31, 2022 | -27.02 |
| Sep 30, 2022 | -49.29 |
| Jun 30, 2022 | -23.84 |
| Mar 31, 2022 | -33.83 |
| Sep 30, 2021 | -22.96 |